grantGrants.gov

Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)

Organization National Institutes of HealthPosted 2 Dec 2024Deadline 16 Nov 2027
HHS-NIH1193.865synopsis
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Explore more

🏷 More HHS-NIH11 opportunities🏷 More 93.865 opportunities🏷 More synopsis opportunities🏢 All Grants.gov opportunities

Full Description

Opportunity Number: PAR-25-266 Document Type: synopsis CFDA Numbers: 93.865

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional) — National Institutes of Health | Dev Procure